The FDA has approved Butrans™ (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time. The Butrans Transdermal System is an analgesic product that delivers a continuous release of medication for seven days.
Butrans is an opioid and is classified as a Schedule III controlled substance. That means there is some potential for abuse, but less than for...


8 Things You Didn't Know About Restless Legs Syndrome
Top 10 Things NOT to Say to a Fibromyalgia Patient
7 Conditions Often Mistaken for Fibromyalgia
7 Surprising Causes of Back Pain